Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Individualized Medicine
August 3, 2016
Featured News
July 31, 2016
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community